High SOX2 Levels Predict Better Outcome in Non-Small Cell Lung Carcinomas

PLoS ONE - United States
doi 10.1371/journal.pone.0061427
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Public Library of Science (PLoS)

Related search

Vascular Phenotype in Angiogenic and Non-Angiogenic Lung Non-Small Cell Carcinomas

British Journal of Cancer
Cancer ResearchOncology
2002English

Cancer Stem Cells in Lung Cancer: Distinct Differences Between Small Cell and Non-Small Cell Lung Carcinomas

2011English

MicroRNAs as Regulators of Cisplatin-Resistance in Non-Small Cell Lung Carcinomas

Oncotarget
Oncology
2017English

MA09.05 Can We Predict Radiosensitivity in Non-Small Cell Lung Cancer?

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

P3.17-05 Multimodality Treatment for Superior Sulcus Non-Small-Cell Lung Carcinomas

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Deep Segmentation Networks Predict Survival of Non-Small Cell Lung Cancer

Scientific Reports
Multidisciplinary
2019English

18f-FMT Uptake Seen Within Primary Cancer on PET Helps Predict Outcome of Non-Small Cell Lung Cancer

Journal of Nuclear Medicine
MedicineNuclear MedicineRadiologyImaging
2009English

SOX2 Is an Oncogene Activated by Recurrent 3q26.3 Amplifications in Human Lung Squamous Cell Carcinomas

PLoS ONE
Multidisciplinary
2010English

Clinical Outcome of Node-Negative Oligometastatic Non-Small Cell Lung Cancer

Thoracic Cancer
MedicinePulmonaryRespiratory MedicineOncology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy